Reaction

Borrelia Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 309 reports · 3 co-occurring drugs

As of the last recalculation, Borrelia Infection appears in 309 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BENDAMUSTINE HCL (PRR 40.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bendamustine Hcl940.240.3
Obinutuzumab937.937.9
Ocrelizumab2023.223.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.